Manufacturer
105 recalls in our database name Lowlite Investments, Inc. D/B/A Olympia Pharmacy as the manufacturing or recalling firm.
Of the 105 recalls from Lowlite Investments, Inc. D/B/A Olympia Pharmacy we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 97 (92%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Olympia Pharmacy is recalling Methylcobalamin and Folic Acid Injection due to FDA inspection findings regarding quality control and sterility assurance.
Olympia Pharmacy is recalling Altrenogest 50 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Lisinopril 20 mg/ml Injection due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling Alprostadil 2000 mcg/ml because FDA inspections raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Betamethasone Phosphate/Acetate 6 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Yohimbine 10 mg/ml Injection because FDA inspection findings raised concerns about quality control and assurance of sterility.
Olympia Pharmacy is recalling Diphenhydramine 50 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Diclazuril 10 mg/ml Injection because FDA inspections raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling compounded ophthalmic drops due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling specific lots of compounded Sodium Tetradecyl Sulfate injections due to FDA inspection findings regarding quality control and sterility assurance.
Olympia Pharmacy is recalling Acepromazine 25 mg/ml Injection because FDA inspection findings raised concerns about quality control processes and assurance of sterility.
Olympia Pharmacy is recalling HACC 270.1 Injection because FDA inspection findings raised concerns about quality control processes and the assurance of sterility.
Olympia Pharmacy is recalling Potassium Phosphate Injection because FDA inspections raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Meloxicam 5 mg/ml Injection because FDA inspections raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Medetomidine 2 mg/ml Injection because FDA inspections raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling compounded Glutathione 200 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Aminocaproic Acid 250 mg/ml Injection due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling Phenobarbital 62.5 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling two lots of compounded Methylcobalamin injections nationwide and in Puerto Rico due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling two lots of compounded Chlorpromazine HCL 100 mg/ml Injection due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling Naproxen 100 mg/ml Injection due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling compounded Progesterone 100 mg/ml in Olive Oil Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Caco/Copper 6.2 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling Metabolase Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling two vials of compounded Deslorelin 15 mg due to FDA inspection findings regarding quality control and lack of assurance of sterility.